Pay in 4 interest-free payments of $5.81 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Salter SJ, Cox MJ, Turek EM, et al
Annie Moore, an internal medicine doctor who is board-certified in obesity medicine and has extensive experience prescribing GLP-1 weight loss medications to her patients
Inconsistency between overall and subgroup analyses
Koeth's 2013 study (PMID 23563705) showed that gut bacteria convert dietary carnitine into trimethylamine, which the liver then oxidizes into TMAO (trimethylamine-N-oxide)
However, the drug is not currently licensed to treat obesity by the FDA in the United States, but it is sometimes prescribed Moreover, Such altered versions of the drug, known as compounded semaglutide, may not contain the same active ingredient as FDA-approved semaglutide products, and have not been shown to be safe and effective, the official warning states, and people should avoid purchasing these compounds
